AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

SVM UK EMERGING FUND PLC

Report Publication Announcement Sep 30, 2018

4798_ir_2018-09-30_b8b615a0-585c-4aab-a08e-a1677982f60a.pdf

Report Publication Announcement

Open in Viewer

Opens in native device viewer

Half Yearly Report 30 September 2018

SVM UK Emerging Fund plc

SVM UK EMERGING FUND PLC (the "Fund") HALF YEARLY REPORT (FOR THE SIX MONTHS TO 30 SEPTEMBER 2018)

A copy of the Half Yearly Report will be available to download from the Manager's website at www.svmonline.co.uk and a copy will shortly be available for inspection at the National Storage Mechanism at www.morningstar.co.uk/uk/nsm. Copies are also available at 7 Castle Street, Edinburgh EH2 3AH, the registered office of the Fund.

HIGHLIGHTS

  • Net asset value return of 14.6% compared to a 7.9% return in the IA UK All Companies Sector Average Index and 8.3% return in the FTSE All-Share Index. The share price rose 38.9%.
  • Positive contributions from Dechra Pharmaceuticals, Watkin Jones, GVC and Hutchison China Meditech.
  • Since the current investment managers took on responsibility for the portfolio in September 2012, net asset value has gained 168.4% against a benchmark return of 64.4%
  • The portfolio is focused on medium-sized and smaller growing businesses, where management can deliver growth via self-help.
  • At 15 November 2018 net asset value was 110.9p.

"Long term capital growth from investments in smaller UK companies. Its aim is to outperform the IA UK All Companies Sector Average Index on a total return basis"

Financial Highlights

Total Return
Performance to 30
September 2018
6 months 3 years 5 Years 10 Years
Net Asset Value +14.6% +60.8% +101.1% +161.8%
Share Price +38.9% +106.6% +126.2% 94.6%
Benchmark Index * +7.9% +34.6% +45.1% +94.5%

* The benchmark index for the Fund was changed to the IA UK All Companies Sector Average Index from 1 October 2013 prior to which the FTSE AIM Index was used.

CHAIRMAN'S STATEMENT

In the period under review, small and medium sized companies outperformed the FTSE 100 Index, which helped the Fund's performance. Over the six months to 30 September 2013, the Company's net asset value increased by 14.6% to 128.4p per share, compared to a return of 7.9% in the benchmark index, the IA UK All Companies Sector Average Index (total return). The subsequent market setback in October, however, brought the Company's net asset value down to 110.4p.

The strongest contributions to performance over the six months came from Dechra Pharmaceuticals, Watkins Jones and Hutchison China Medical. These are all growing businesses which operate with innovative strategies. Each has a business model that is scalable, with limited need for additional external capital. The main disappointment over the period was Hostelworld.

A number of portfolio stocks that were hardest hit since the end of August were also those that have still performed well for the year to date. Profit taking is a stock market pattern from time to time. These stocks include Burford, Fevertreee Drinks and JD Sports Fashion. The Managers believe that these companies are best in class in their sector, giving them better profit margins and superior growth prospects. A number of less well researched stocks were also weaker performers, including urban regeneration specialist, Sigma Capital and Mortgage Advice Bureau, but the Managers believe these companies have the potential to grow from their current niches into substantial businesses since they possess a clear competitive edge. Most are capital-lite and cash generative, so should not need distress fundraisings.

The portfolio has low exposure to some areas of cyclical risk, such as banks, mining and industrials, which may be more challenged in any slowdown. Many of the portfolio companies operate in a niche where there is an ongoing need for business investment, or which benefit from a change in consumer demand. For many of these, such as Burford, JD Sports Fashion and Fevertree Drinks, this is not primarily based on technology. Quite a number of these businesses have considerable US potential, such as Applegreen (filling stations and food) and GVC (US gambling liberalisation). One area of portfolio emphasis that has been unhelpful recently is travel, but these holdings should be helped by the pick-up in real wage growth in the UK.

After good performance, the gains in Redrow, Mattioli Woods, Dotdigital Group, Johnson Service and Severfield were realised. Reinvestment was made into a number of growing businesses, including Ocado and Draper Esprit. |New, smaller company, investments include Team 17, Scancell, Nucleus Financial Group and Aquis Exchange. These portfolio changes increase the emphasis on specialist medium and smaller size companies addressing growth markets.

The Board reviewed its fee arrangements in September and made the decision to re-instate the Investment Management Agreement Fee, payable with effect from I October 2018, under the terms set out in the Investment Management Agreement. The Board also accepted the Manager's request to delete reference to payment of an incentive fee. SVM Asset Management Limited provides management and secretarial services to the Company and is entitled to a fee for these services, payable quarterly in arrears equivalent to 0.75% per annum (plus VAT) of the total assets of the Company, less current liabilities.

In addition, the Company approved changes to the Director's fees. Non-executive Directors are not eligible for bonuses, pension benefits or other benefits. The revised fees are now at the original levels set at the inception of the Fund, being £10,000 for the Chairman and £7,500 for each of the non-executive directors.

The portfolio emphasises exposure to scalable businesses with a competitive edge that can deliver above average growth. The Fund remains fully invested and is currently making use of its ability to apply gearing to increase its market exposure.

INVESTMENT OBJECTIVE and POLICY

The investment objective of SVM UK Emerging Fund plc (the "Fund" or the "Company") is long term capital growth from investments in smaller UK companies. Its aim is to outperform the IA UK All Companies Sector Average Index on a total return basis

The Fund aims to achieve its objective and to diversify risk by investing in shares and related instruments, controlled by a number of limits on exposures. Appropriate guidelines for the management of the investments, gearing and financial instruments have been established by the Board. This is an abridged version of the Fund's investment policy. The full investment policy can be found in the Strategic Report within the Fund's latest Annual Report & Accounts.

DIRECTORS' RESPONSIBILITY STATEMENT

The Directors are responsible for preparing the Half Yearly Report in accordance with applicable law and regulations.

The Directors confirm that to the best of their knowledge:

  • (i) the condensed set of financial statements have been prepared in accordance with the Financial Reporting Council Statement 104 "Interim Financial Reporting" on a going concern basis and give a true and fair view of the assets, liabilities, financial position and profit or loss of the Fund;
  • (ii) the Half Yearly Report includes a fair review of the information required by the Disclosure and Transparency Rules DTR 4.2.7R (indication of important events during the first six months and description of principal risks and uncertainties for the remaining six months of the year); and DTR 4.2.8R (disclosure of related party transactions and changes therein).

(iii) No related party transactions have taken place during the first six months of the year that have materially affected the financial position of the Fund during the period and there have been no changes in the related party transactions described in the Annual Report & Accounts for the year end 31 March 2018 that could do so.

The Directors consider that the Half Yearly Report, taken as a whole, is fair, balanced and understandable and provides the information necessary for shareholders to assess the Fund's performance and strategy,

The Half Yearly Report has not been audited or reviewed by the Fund's auditors.

By Order of the Board Peter Dicks Chairman 16 November 2018

Income Statement

Six months to 30 September
2018
Six months to 30 September
2017
Revenue
£'000
Capital
£'000
Total
£'000
Revenue
£'000
Capital
£'000
Total
£'000
Net gain on investments at fair value - 950 950 - 753 753
Income 86 - 86 95 - 95
Investment management fees - - - - - -
Other expenses (32) - (32) (32) (4) (36)
Gain before finance costs and
taxation 54 950 1,004 63 749 812
Finance costs (22) - (22) (10) - (10)
Gain on ordinary activities before
taxation 32 950 982 53 749 802
Taxation (2) - (2) - - -
Gain attributable to ordinary
shareholders
30 950 980 53 749 802
Gain per Ordinary Share 0.50p 15.82p 16.32p 0.88p 12.48p 13.36p
Year ended 31 March 2018
(audited)
Revenue
£'000
Capital
£'000
Total
£'000
Net gain on investments at fair value - 1,019 1,019
Income 141 - 141
Investment management fees - - -
Other expenses (62) (7) (69)
Gain before finance costs and
taxation
79 1,012 1,091
Finance costs (23) - (23)
Gain on ordinary activities before
taxation
56 1,012 1,068
Taxation 1 - 1
Gain attributable to ordinary
shareholders
57 1,012 1,069
Gain per Ordinary Share 0.94p 16.83p 17.77p

The Total column of this statement is the profit and loss account of the Fund. All revenue and capital items are derived from continuing operations. No operations were acquired or discontinued in the year. A Statement of Comprehensive Income is not required as all gains and losses of the Fund have been reflected in the above statement.

Balance Sheet

As at
30 September
2018
(unaudited)
£'000
As at
31 March
2018
(audited)
£'000
As at
30 September
2017
(unaudited)
£'000
7,435 6,480 6,307
376 435 382
(102) (186) (227)
274 249 155
7,709 6,729 6,462
7,709 6,729 6,462
7,709 6,729 6,462
128.38p 112.05p 107.61p

Statement of Changes in Equity

For the period to 30 September 2018

Capital
Share Share Special redemption Capital Revenue
capital premium reserve reserve reserve reserve
£'000 £'000 £'000 £'000 £'000 £'000
As at 1 April 2018 300 314 5,144 27 1,323 (379)
Gain attributable to shareholders - - - - 950 30
As at 30 September 2018 300 314 5,144 27 2,273 (349)

For the year to 31 March 2018

Share
capital
£'000
Share
premium
£'000
Special
reserve
£'000
Capital
redemption
reserve
£'000
Capital
reserve
£'000
Revenue
reserve
£'000
As at 1 April 2017
Gain attributable to shareholders
300
-
314
-
5,144
-
27
-
311
1,012
(436)
57
As at 31 March 2018 300 314 5,144 27 1,323 (379)

For the period to 30 September 2017

Share
capital
£'000
Share
premium
£'000
Special
reserve
£'000
Capital
redemption
reserve
£'000
Capital
reserve
£'000
Revenue
reserve
£'000
As at 1 April 2017 300 314 5,144 27 311 (436)
Gain attributable to shareholders - - - - 749 53
As at 30 September 2017 300 314 5,144 27 1,060 (383)

Investment Portfolio as at 30 September 2018

Stock Market
Exposure
2018
£000
% of
Net
Assets
Sector analysis as at 30
September 2018
Sector
% of
Gross
Exposure
1 Fevertree Drinks 400 5.2 Consumer Goods 23.3
2 Burford Capital 372 4.8 Consumer Services 19.8
3 Learning Technologies Group 364 4.7 Financials 19.1
4 Blue Prism Group 274 3.6 Healthcare 14.5
5 Unite Group 253 3.3 Industrials 12.8
6 GVC Holdings 246 3.2 Technology 9.6
7 4Imprint Group 240 3.1 Telecommunications 0.9
8 Hutchison China Meditech 232 3.0 Total 100.0
9 Workspace Group 228 3.0
10 Hilton Food Group 212 2.8
Ten largest investments 2,821 36.7
11 GB Group* 208 2.7
12 Beazley 179 2.3
13 Kerry Group 177 2.3
14 FDM Group 160 2.1
15 Zoo Digital Group 159 2.1
16 DiscoverIE Group* 157 2.0
17 Johnson Service Group 155 2.0
18 ASOS 154 2.0
19 Learning Technologies* 149 1.9
20 K3 Capital Group 147 1.9
Twenty largest investments 4,466 58.0
21 Applegreen 146 1.9
22 JD Sports Fashion* 146 1.9
23 Cineworld Group 144 1.9
24 Rentokil Initial 143 1.8
25 SSP Group 139 1.8
26 Hostelworld Group 128 1.7
27 Dechra Pharmaceuticals 124 1.6
28 Imimobile 119 1.5
29 Watkin Jones 117 1.5
30 UDG Healthcare 112 1.4
Thirty largest investments 5,784 75.0 *Includes Contract for Difference (CFD)
Other investments (33 holdings) 3,514 45.6
Total investments 9,298 120.6
CFD positions exposure (1,916) (24.9) Market exposure for equity investments held
is the same as fair value and for CFDs held
CFD unrealised gains 53 0.7 is the market value of the underlying shares
Net current assets 274 3.6 to which the portfolio is exposed via the
Net assets 7,709 100.0 contract.
% of
Gross
Exposure

Risks and Uncertainties

The principal risks facing the Fund relate to the investment in financial instruments and include market, liquidity, credit and interest rate risk. Additional risks faced by the Fund are investment strategy, share price discount, accounting, legal and regulatory, operational, corporate governance and shareholder relations, and financial. The Board seeks to mitigate and manage these risks through continuous review, policy setting and enforcement of contractual obligations. The Board receives both formal and informal reports from the Managers and third party service providers addressing these risks. An explanation of these risks and how they are mitigated is explained in the 2018 Annual Report, which is available on the Manager's website: www.svmonline.co.uk. These principal risks and uncertainties have not changed from those disclosed in the 2018 Annual Report.

Going Concern

The Board, having made appropriate enquiries, has a reasonable expectation that the Fund has adequate resources to continue in operational existence for the foreseeable future, a period of not less than 12 months from the date of this report. Accordingly, it continues to adopt the going concern basis in preparing the financial statements.

Notes

    1. The Financial Statements have been prepared on a going concern basis in accordance with FRS 102 "Financial Reporting Standard applicable in the UK and Republic of Ireland", FRS 104 "Interim Financial Reporting" and under the Association of Investment Companies Statement of Recommended Practice "Financial Statement of Investment Trust Companies and Venture Capital Trusts" issued in 2014, as were the interim financial statements for the period to 30 September 2017. The requirements have been met to qualify for the exemption to prepare a Cash Flow Statement, this has therefore been removed. These financial statements have been prepared in accordance with the accounting policies used for the financial year ended 31 March 2018.
    1. Return per share is based on a weighted average of 6,005,000 (2017 6,005,000) ordinary shares in issue during the period.

Total return per share is based on the total gain for the period of £980,000 (2017 – gain of £802,000). Capital return per share is based on the capital gain for the period of £950,000 (2017 – gain of £749,000). Revenue return per share is based on the revenue gain after taxation for the period of £30,000 (2017 - gain of £53,000).

The number of shares in issue at 30 September 2018 was 6,005,000 (2017 – 6,005,000).

  1. All investments are held at fair value. At 30 September 2018 no unlisted investments were held with value attributed (31 March 2018: same; 30 September 2017: same).
September March
2018 2018
£000 £000
Classification of financial instruments
Level 1 7,382 6,464
Level 2 53 16
Level 3 – 2 investments (March 2018 – 2) - -

Investments have been classified using the fair value hierarchy:

Level 1 reflects financial instruments quoted in an active market.

Level 2 reflects financial instruments whose fair value is evidenced by comparison with other observable current market transactions in the same instrument or based on a valuation technique whose variables includes only data from observable markets. The CFD positions are the sole Level 2 investments at 30 September 2018 and 31 March 2018

Level 3 reflects financial instruments whose fair value is determined in whole or in part using a valuation technique based on assumptions that are not supported by prices from observable market transactions in the same instrument and not based on available observable market data.

  1. The Board has granted the Manager a limited authority to invest in CFDs to achieve some degree of gearing and/or hedging without incurring the gross cost of the investment. The Board requires the Manager to operate within certain risk limits, as detailed in the Annual Report. The following table details the CFD positions:
CFD positions September March
2018 2018
£000 £000
Gross exposure 1,916 1,668
Net exposure 1,916 1,668
Unrealised gains 53 16
Unrealised losses 113 98

Number of CFD holdings at 30 September 2018: 22 (31 March 2018: 20)

The gearing ratio is 24.9% at 30 September 2018 (31 March 2018: 25.6%). The gearing figure indicates the extra amount by which the shareholders' funds would change if total assets (including CFD position exposure and netting off cash and cash equivalents) were to rise or fall. A figure of zero per cent means that the Company has a nil geared position.

    1. The Manager has waived its fees for the periods to 30 September 2018 and 2017.
    1. The above figures do not constitute full or statutory accounts in terms of Sections 434 and 435 of the Companies Act 2006. All information shown for the six months to 30 September 2018 is unaudited. The accounts for the year to 31 March 2018, on which the auditors issued an unqualified report, have been lodged with the Registrar of Companies and did not contain a statement required under Section 498 of the Companies Act 2006.

CORPORATE INFORMATION

Directors

Peter Dicks (Chairman) Richard Bernstein Anthony Puckridge

Investment Manager, Secretary and Registered Office

SVM Asset Management Limited 6 th Floor 7 Castle Street Edinburgh EH2 3AH Telephone: +44 (0) 0131 226 6699 Facsimile: +44 (0) 131 226 7799 Email: [email protected] Web: www.svmonline.co.uk

Registrars

Computershare Investor Services plc Leven House, 10 Lochside Place Edinburgh Park Edinburgh EH12 9RG Telephone: +44 (0) 370 702 0003

Auditor

Scott-Moncrieff Exchange Place 3 Semple Street Edinburgh EH3 8BL

Custodians State Street Bank & Trust Company

Registered Number SC211841

Company Website www.svmonline.co.uk

Talk to a Data Expert

Have a question? We'll get back to you promptly.